RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
13.29
0.05 (0.38%)
At close: May 15, 2025, 3:59 PM
13.33
0.26%
Pre-market: May 16, 2025, 09:27 AM EDT

RxSight Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2021
L D D Revenue 39.7M 13.77M
L D D Revenue Growth +188.25% n/a
RxLAL Revenue 96.5M 656K
RxLAL Revenue Growth +14609.91% n/a
Service Warranty Service Contracts And Accessories Revenue 3.73M n/a
Service Warranty Service Contracts And Accessories Revenue Growth n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 28.64M 28.21M 25.61M 24.29M 23.32M 21.16M 19.14M 18.24M 16.25M 15.73M 14.93M 14.39M 13.62M 11.62M 9.08M 6.5M 5.61M 4.4M 3.83M 3.25M 3.7M
Selling, General, and Administrative Revenue Growth +1.51% +10.16% +5.42% +4.15% +10.20% +10.57% +4.95% +12.21% +3.33% +5.39% +3.74% +5.64% +17.22% +28.02% +39.59% +15.88% +27.44% +15.11% +17.73% -12.14% n/a
Research and Development Revenue 10.37M 9.21M 8.84M 8.29M 8.03M 7.34M 7.1M 7.4M 7.21M 6.68M 6.39M 6.19M 6.72M 5.92M 5.38M 6.56M 6.64M 5.27M 5.8M 5.08M 5.78M
Research and Development Revenue Growth +12.60% +4.18% +6.60% +3.24% +9.40% +3.38% -4.05% +2.68% +7.89% +4.59% +3.17% -7.84% +13.57% +10.02% -18.07% -1.20% +26.01% -9.12% +14.10% -12.00% n/a